(EMAILWIRE.COM, April 04, 2019 ) This market is highly fragmented with the presence of many local, regional, and global players. Various small and medium-sized players operating in both developed and emerging markets are making this a highly competitive market.

The companies in this market are mainly focusing on expansions and acquisitions to strengthen their product offerings and establish a strong geographical foothold. In 2017, the market is primarily dominated by DowDuPont (US), Roquette (France), Ashland (US), and BASF (Germany).

DowDuPont dominated the pharmaceutical excipients market in 2017. The company brings together the complementary portfolios of Dow and DuPont, making it one of the world’s largest chemical corporation. The acquisition of FMC’s Health & Nutrition business in November 2017 alleviated the company’s position in the global pharmaceutical excipients market bringing an extensive range of products under one roof.

The company offers a comprehensive portfolio of excipients ranging from rheology modifiers, tablet coatings, controlled release, stabilizers, solubilizers, binding agents, and masking agents to name a few.

Download the PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=956

The company is largely known for its diversified cellulose compound offerings for the pharmaceutical industry. Its position among the top pharmaceutical excipient manufacturers is attributed to its global footprint through distributors and agents. The company is highly focused on conducting strategic agreements and expansions of its functional units. For instance, in December 2015, The Dow Chemical Company entered into a definitive agreement to acquire full ownership of Dow Corning Corporation (US).

Under the terms of the agreement, Dow will become the owner of Dow Corning which currently is a 50:50 joint venture between Dow Chemical Company and Dow Corning Inc. (US). The company also pursues the strategy of agreements and partnerships with well-known science and technology universities to enhance its presence in the pharmaceutical excipients market. The company intends to strengthen its presence in the market by delivering superior solutions and choices to customers. The firm strongly believes that investments in R&D offer great potential for short and long-term growth.

Roquette is the second-largest market player in the pharmaceutical excipients market. This is mainly attributed to its exhaustive portfolio of diluents, binders, coatings agents, sweeteners, and dispersants. This company is growing at a rapid pace in this market, by adopting various organic and inorganic growth strategies. In line with this, Roquette acquired Co Itacel, the excipient division of Blanver in Brazil in September 2017. This acquisition positively impacted the company’s revenue and increased its market presence in the North and Latin American regions.

The company also launched new excipients in the market in January 2018, along with three new excipient brands in March 2017. The company has a strong presence in the European region which is one of the major markets for its pharmaceutical excipients. Additionally, the firm also focuses on expanding its business globally to further strengthen its position in the market. For this, it aims to expand its business in high-growth regions such as Asia Pacific and Latin America.

Some of the other players competing in this market are Ashland (US), BASF (Germany), Kerry Group (Ireland), Evonik (Germany), Associated British Foods (UK), Archer Daniels Midland Company (US), Lubrizol (US), Croda (UK), Innophous Holdings (US), WACKER CHEMIE (Germany), and Signet (India).

Get the Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=956

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com